Berlin, Germany

Daniel Zickler



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Zickler

Introduction

Daniel Zickler is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical technology, particularly in the area of hemodialysis. With a total of two patents to his name, Zickler's work focuses on improving treatment options for patients with vascular calcifications.

Latest Patents

Zickler's latest patents include a permselective membrane designed for treating vascular calcifications in chronic hemodialysis patients. This innovative hemodialysis membrane is characterized by its unique composition, which includes at least one hydrophobic polymer and at least one hydrophilic polymer. The membrane has a molecular weight retention cutoff (MWRO) of between 15 and 20 kD and a molecular weight cutoff (MWCO) of between 170-320 kD. Alternatively, it can also have a MWRO of between 8.5 kD and 14.0 kD and a MWCO of between 55 kD and 130 kD. This invention aims to enhance the treatment of vascular calcification in hemodialysis patients, providing a more effective solution for those suffering from this condition.

Career Highlights

Throughout his career, Daniel Zickler has worked with prominent organizations such as Gambro Lundia AB and Charité-Universitätsmedizin Berlin. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Zickler has collaborated with notable colleagues, including Markus Storr and Bernd Krause. These partnerships have played a crucial role in the development of his patents and innovations.

Conclusion

Daniel Zickler's contributions to the field of hemodialysis through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the medical technology landscape, providing hope for better treatment options for chronic hemodialysis patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…